Martina E. Spehlmann

3.4k total citations · 1 hit paper
45 papers, 2.5k citations indexed

About

Martina E. Spehlmann is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Martina E. Spehlmann has authored 45 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 14 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Martina E. Spehlmann's work include Inflammatory Bowel Disease (17 papers), Microscopic Colitis (8 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Martina E. Spehlmann is often cited by papers focused on Inflammatory Bowel Disease (17 papers), Microscopic Colitis (8 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Martina E. Spehlmann collaborates with scholars based in Germany, United States and Belgium. Martina E. Spehlmann's co-authors include Lars Eckmann, Stefan Schreiber, Andreas Raedler, S. Ott, Patricia Lepage, Norbert Frey, Robert Häsler, Paul Rutgeerts, Douglas C. Wolf and Richard N. Fedorak and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Martina E. Spehlmann

41 papers receiving 2.5k citations

Hit Papers

Twin Study Indicates Loss of Interaction Between Microbio... 2011 2026 2016 2021 2011 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martina E. Spehlmann Germany 18 1.1k 987 699 623 374 45 2.5k
Bernard Khor United States 22 1.3k 1.2× 1.1k 1.1× 1.1k 1.6× 639 1.0× 461 1.2× 36 3.3k
Eleonora A. Festen Netherlands 23 1.0k 0.9× 1.1k 1.1× 517 0.7× 592 1.0× 574 1.5× 70 2.4k
Jesús K. Yamamoto‐Furusho Mexico 29 738 0.7× 1.3k 1.4× 1.1k 1.5× 864 1.4× 604 1.6× 176 3.1k
Hafid O. Al‐Hassi United Kingdom 26 900 0.8× 652 0.7× 776 1.1× 406 0.7× 470 1.3× 68 2.9k
Dominique Berrebi France 32 1.2k 1.1× 849 0.9× 785 1.1× 652 1.0× 886 2.4× 83 3.2k
Paolo Biancheri Italy 26 705 0.6× 1.2k 1.3× 1.2k 1.7× 662 1.1× 600 1.6× 63 3.0k
David Bernardo Spain 29 745 0.7× 505 0.5× 805 1.2× 452 0.7× 415 1.1× 101 2.5k
Sushila Dalal United States 24 941 0.9× 911 0.9× 285 0.4× 870 1.4× 636 1.7× 90 2.2k
Kristen O. Arseneau United States 26 723 0.7× 789 0.8× 589 0.8× 556 0.9× 545 1.5× 36 2.3k
Andreas Lügering Germany 28 596 0.5× 681 0.7× 960 1.4× 697 1.1× 409 1.1× 58 2.6k

Countries citing papers authored by Martina E. Spehlmann

Since Specialization
Citations

This map shows the geographic impact of Martina E. Spehlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina E. Spehlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina E. Spehlmann more than expected).

Fields of papers citing papers by Martina E. Spehlmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina E. Spehlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina E. Spehlmann. The network helps show where Martina E. Spehlmann may publish in the future.

Co-authorship network of co-authors of Martina E. Spehlmann

This figure shows the co-authorship network connecting the top 25 collaborators of Martina E. Spehlmann. A scholar is included among the top collaborators of Martina E. Spehlmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina E. Spehlmann. Martina E. Spehlmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahrens, M, Tolgor Bau, Fabian Moser, et al.. (2025). De novo pulmonary vein isolation in obese vs nonobese patients under deep sedation: Does obesity increase procedure complexity?. Heart Rhythm O2. 6(10). 1524–1535.
2.
Reinecke, Alexander, et al.. (2025). In Heart Failure, Echocardiographic Parameters of Right Ventricular Function are Powerful Tools to Predict Renal Failure. ESC Heart Failure. 12(3). 2310–2320. 1 indexed citations
3.
Moser, Fabian, et al.. (2025). Bipolar Catheter Ablation as a Key for Successful Treatment of Intramural VentricuLar Arrhythmias: Results From the Bipolar‐Kiel Study. Journal of Cardiovascular Electrophysiology. 36(11). 2797–2807.
4.
Spehlmann, Martina E., Ashraf Yusuf Rangrez, Dhiraj Dhotre, et al.. (2022). Heart Failure Severity Closely Correlates with Intestinal Dysbiosis and Subsequent Metabolomic Alterations. Biomedicines. 10(4). 809–809. 16 indexed citations
5.
Müller, Oliver J., Martina E. Spehlmann, & Norbert Frey. (2018). Cardio-toxicity of checkpoint inhibitors. Journal of Thoracic Disease. 10(S35). S4400–S4404. 20 indexed citations
6.
Luedde, Mark, Martina E. Spehlmann, Hans‐Joerg Hippe, et al.. (2018). Serum levels of kisspeptin are elevated in critically ill patients. PLoS ONE. 13(10). e0206064–e0206064. 10 indexed citations
7.
Luedde, Mark, Femke‐Anouska Heinsen, Malte Rühlemann, et al.. (2017). Heart Failure is Associated with Depletion of Core Intestinal Microbiota. ESC Heart Failure. 4(3). 282–290. 232 indexed citations
8.
Bartsch, Kareen, Markus Daμμe, Konrad Aden, et al.. (2017). Absence of RNase H2 triggers generation of immunogenic micronuclei removed by autophagy. Human Molecular Genetics. 26(20). 3960–3972. 149 indexed citations
9.
Feldkamp, Thorsten, Martina E. Spehlmann, Sandra Freitag‐Wolf, et al.. (2017). Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures. Clinical Research in Cardiology. 107(2). 148–157. 23 indexed citations
10.
Bauer, Jessica, Özkan Özden, Naomi Akagi, et al.. (2015). Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer. Molecular Cancer. 14(1). 182–182. 53 indexed citations
11.
Häsler, Robert, Zhe Feng, Liselotte Bäckdahl, et al.. (2012). A functional methylome map of ulcerative colitis. Genome Research. 22(11). 2130–2137. 98 indexed citations
12.
Spehlmann, Martina E., et al.. (2011). Risk factors in German twins with inflammatory bowel disease: Results of a questionnaire-based survey. Journal of Crohn s and Colitis. 6(1). 29–42. 30 indexed citations
13.
Lepage, Patricia, Robert Häsler, Martina E. Spehlmann, et al.. (2011). Twin Study Indicates Loss of Interaction Between Microbiota and Mucosa of Patients With Ulcerative Colitis. Gastroenterology. 141(1). 227–236. 469 indexed citations breakdown →
14.
Jeníková, Gabriela, Elaine Hanson, Martina E. Spehlmann, et al.. (2010). Coordinate Down-regulation of Adenylyl Cyclase Isoforms and the Stimulatory G Protein (Gs) in Intestinal Epithelial Cell Differentiation. Journal of Biological Chemistry. 285(17). 12504–12511. 13 indexed citations
15.
Sandborn, William J., María T. Abreu, Geert D’Haens, et al.. (2010). Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab. Clinical Gastroenterology and Hepatology. 8(8). 688–695.e2. 119 indexed citations
16.
Spehlmann, Martina E., Sara M. Dann, Petr Hrúz, et al.. (2009). CXCR2-Dependent Mucosal Neutrophil Influx Protects against Colitis-Associated Diarrhea Caused by an Attaching/Effacing Lesion-Forming Bacterial Pathogen. The Journal of Immunology. 183(5). 3332–3343. 84 indexed citations
17.
Spehlmann, Martina E. & Lars Eckmann. (2009). Nuclear factor-kappa B in intestinal protection and destruction. Current Opinion in Gastroenterology. 25(2). 92–99. 134 indexed citations
18.
Dann, Sara M., Martina E. Spehlmann, Mitsutoshi Iimura, et al.. (2008). IL-6-Dependent Mucosal Protection Prevents Establishment of a Microbial Niche for Attaching/Effacing Lesion-Forming Enteric Bacterial Pathogens. The Journal of Immunology. 180(10). 6816–6826. 156 indexed citations
19.
Targan, Stephan R., Brian G. Feagan, Richard N. Fedorak, et al.. (2007). Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial. Gastroenterology. 132(5). 1672–1683. 459 indexed citations
20.
Musch, E., Tilo Andus, Wolfgang Kruis, et al.. (2005). Interferon-β-1a for the Treatment of Steroid-Refractory Ulcerative Colitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Clinical Gastroenterology and Hepatology. 3(6). 581–586. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026